MM-093

DRUG4 trials

Sponsors

Merrimack Pharmaceuticals

Conditions

PsoriasisRheumatoid ArthritisUveitis

Phase 2

Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)

CompletedNCT00105976

Merrimack PharmaceuticalsRheumatoid Arthritis

Start: 2005-02-28Target: 260Updated: 2008-07-11

Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis

CompletedNCT00147329

Merrimack PharmaceuticalsPsoriasis

Start: 2005-09-30End: 2006-07-31Target: 30Updated: 2007-02-23

Phase 2 Study of MM-093 to Treat Patients With Uveitis

CompletedNCT00444743

Merrimack PharmaceuticalsUveitis

Start: 2007-02-28Target: 20Updated: 2008-12-18

A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis

CompletedNCT00458146

Merrimack PharmaceuticalsRheumatoid Arthritis

Start: 2007-02-28Target: 100Updated: 2008-03-27